04/14/2026
CMS confirmed the diabetic eye exam measure is here to stay.
When CMS proposed removing the measure, the industry had an overwhelming response: routine retinal screening is one of the most efficient, non-invasive tools available to identify eye disease and prevent blindness.
Commenters also reminded CMS what's at stake beyond the eye exam itself. Preventing vision loss reduces costly late-stage treatment, functional decline, caregiver burden, and long-term care costs.
This measure isn't just about checking a box. It's one of the most consequential preventive care levers in diabetes management.
We help your teams close this gap at the point of care, where patients already are, driving better access and better outcomes.
The measure is here to stay. Is your workflow ready?
Let's talk about how we're helping our clients perform on what matters most.
Medicare Beneficiaries to See Simpler and More Flexible Plan Choices, Better Drug Coverage, Higher Quality and Lower Costs in 2027